Screener
Haemonetics HAE Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Net revenues | $339,380 | $321,394 |
| Cost of goods sold | 136,577 | 129,150 |
| Gross profit | 202,803 | 192,244 |
| Operating expenses: | ||
| Research and development | 16,200 | 16,261 |
| Selling, general and administrative | 118,941 | 110,719 |
| Amortization of acquired intangible assets | 10,204 | 11,392 |
| Total operating expenses | 145,345 | 138,372 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's total revenue?
- Haemonetics (HAE) reported total revenue of $339.38M in Q2 2026.
- How has Haemonetics's total revenue changed year-over-year?
- Haemonetics's total revenue increased by 5.6% year-over-year, from $321.39M to $339.38M.
- What is the long-term trend for Haemonetics's total revenue?
- Over 4 years (2022 to 2026), Haemonetics's total revenue has grown at a 7.7% compound annual growth rate (CAGR), from $993.2M to $1.33B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Haemonetics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude